Video Experimental Relacionado
Updated: Aug 10, 2026

06:11
Culturing Primary Rat Inner Medullary Collecting Duct Cells
Published on: June 21, 2013
El captopril (SQ 14225) disminuye el consumo de alcohol y la aldosterona en ratas que carecen de vasopresina
Nature
|October 18, 1979
Resumen
En ratas con diabetes insipidus (DI), la inhibición de la angiotensina II redujo el consumo de alcohol. Esto sugiere que la angiotensina II elevada contribuye a la sed excesiva en DI, afectando el equilibrio hídrico.
Área de la Ciencia:
- Endocrinología Endocrinología.
- Fisiología Fisiología Fisiología.
- Nefrología Nefrología.
Sus antecedentes:
- La angiotensina II (Ang II) estimula la sed (dipsogénica), mientras que la vasopresina (hormona antidiurética, ADH) regula la excreción de agua.
- Juntos, Ang II y ADH son cruciales para mantener la homeostasis del agua de los mamíferos.
- Las ratas Brattleboro con diabetes insipidus hereditaria (DI), que carecen de ADH, sirven como modelo para estudiar el metabolismo del agua.
Objetivo del estudio:
- Investigar el papel de Ang II en la polidipsia observada en ratas DI.
- Para determinar los efectos de la inhibición de la síntesis de Ang II en la ingesta de agua y los perfiles hormonales en ratas DI.
Principales métodos:
- Las ratas DI Brattleboro fueron tratadas con captopril (SQ 14225), un inhibidor de la enzima de conversión de la angiotensina (ECA).
- Se midieron las tasas de consumo de alcohol, la aldosterona plasmática y la actividad de la renina plasmática.
- Se evaluaron los cambios hormonales y el balance hídrico en respuesta a la inhibición de la ECA.
Principales resultados:
- La administración de captopril redujo significativamente las tasas de consumo de alcohol en ratas DI.
- Después de seis días de tratamiento, las concentraciones plasmáticas periféricas de aldosterona disminuyeron, coincidiendo con la hipercalemia.
- Se observaron elevadas actividades plasmáticas de renina y concentraciones de Ang II en las ratas DI no tratadas.
Conclusiones:
- La polidipsia asociada con la diabetes insipida se debe en parte a la actividad elevada de la renina plasmática y los niveles de Ang II.
- El hipoaldosteronismo observado en las ratas DI Brattleboro puede estar influenciado por el metabolismo de esteroides específico del tejido y la sensibilidad adrenocortical alterada.
- Estos hallazgos ponen de relieve la compleja interacción de las hormonas en la regulación del equilibrio hídrico, particularmente en estados de deficiencia de ADH.
Videos de Conceptos Relacionados
Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

